Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Upadacitinib

    Virtual Booth

    Contact Supplier

    HealthTech BioActives, leading globally in Flavonoids and Vitamin B12 Derivatives.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Upadacitinib

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Menu

    Upadacitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 77,355Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3AbbVie Corporation

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    AbbVie Corporation

    UPADACITINIB
    arrow
    Organic Process R&D
    Not Confirmed

    AbbVie Corporation

    Country
    arrow
    Organic Process R&D
    Not Confirmed

    Patent Expiration Date : 2030-12-01

    Date Granted : 2018-02-13

    UPADACITINIB

    Brand Name : RINVOQ

    Patent Number : 2781891

    Filing Date : 2010-12-01

    Strength per Unit : 15 mg

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2030-12-01

    Date Granted : 2018-02-13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    AbbVie Corporation

    UPADACITINIB
    arrow
    Organic Process R&D
    Not Confirmed

    AbbVie Corporation

    Country
    arrow
    Organic Process R&D
    Not Confirmed

    Patent Expiration Date : 2030-12-01

    Date Granted : 2018-02-13

    UPADACITINIB

    Brand Name : RINVOQ

    Patent Number : 2781891

    Filing Date : 2010-12-01

    Strength per Unit : 30mg

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2030-12-01

    Date Granted : 2018-02-13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    AbbVie Corporation

    UPADACITINIB
    arrow
    Organic Process R&D
    Not Confirmed

    AbbVie Corporation

    Country
    arrow
    Organic Process R&D
    Not Confirmed

    Patent Expiration Date : 2030-12-01

    Date Granted : 2018-02-13

    UPADACITINIB

    Brand Name : RINVOQ

    Patent Number : 2781891

    Filing Date : 2010-12-01

    Strength per Unit : 45mg

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2030-12-01

    Date Granted : 2018-02-13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF